Inhalation Toxicologist, Pharmacology, Early Development
Emily Resseguie earned her Ph.D. in Toxicology from the University of Rochester School of Medicine and Dentistry (2016), after obtaining a B.S. in Biology from Calvin College (2010). Her graduate studies focused on the mechanisms of oxygen toxicity. She designed and conducted research projects to determine the relationship between the genotoxic stress response and activation of a possibly adaptive response to an oxidative environment. She published first author and co-author peer-reviewed articles, and was a member of the American Thoracic Society and Society of Toxicology while pursuing her doctorate.
Emily joined Labcorp (formerly Envigo) as a Study Director and was responsible for the overall design, conduct, interpretation, and reporting of general toxicity studies, with an emphasis on inhalation studies, in both rodent and non-rodent species. After about 4 years she became an Inhalation Toxicologist within the company and now provides scientific leadership and strategy primarily for inhalation toxicology. She is responsible for training and mentoring of staff, and oversite of data acquisition, analysis, and reporting for the specialty. She advises internal staff and clients on regulatory requirements for the discipline, provides guidance on client proposals and study design, serves as a key interface with clients, and promotes the expertise of the team in study execution and scientific guidance.